Cargando…
Clinical utility of 0.025-inch guidewire VisiGlide2(TM) in the endoscopic retrograde cholangiopancreatography-related procedures
AIM: To examine the result of the use of 0.025-inch guidewire (GW) VisiGlide2(TM) as the first choice in the endoscopic retrograde cholangiopancreatography (ERCP)-related procedures without selecting the patient in a multicenter prospective study. METHODS: ERCP using 0.025-inch GW VisiGlide2(TM) as...
Autores principales: | Sakai, Yuji, Tsuyuguchi, Toshio, Hirata, Nobuto, Nakaji, So, Shimura, Kenji, Nishikawa, Takao, Fujimoto, Tatsuya, Hamano, Tetsuya, Nishino, Takayoshi, Yokosuka, Osamu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Baishideng Publishing Group Inc
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5311476/ https://www.ncbi.nlm.nih.gov/pubmed/28250900 http://dx.doi.org/10.4253/wjge.v9.i2.77 |
Ejemplares similares
-
Experimental study of loop shape using 0.025-inch ERCP guidewires (with videos)
por: Ogura, Takeshi, et al.
Publicado: (2021) -
Steerable-wire technique using high-flow steerable microcatheter and 0.025-inch guidewire
por: Maruyama, Mitsunari, et al.
Publicado: (2023) -
Impact of guidewire caliber on ERCP outcomes: Systematic review and meta-analysis comparing 0.025- and 0.035-inch guidewires
por: Aziz, Muhammad, et al.
Publicado: (2022) -
The feasibility of pancreatic duct stenting using a novel 4-Fr plastic stent with a 0.025-in. guidewire
por: Nagai, Kazumasa, et al.
Publicado: (2021) -
Comparison of efficacy and safety of topical 1% nadifloxacin and tretinoin 0.025% combination therapy with 1% clindamycin and tretinoin 0.025% combination therapy in patients of mild-to-moderate acne
por: Deshmukh, Swapnil Narayan, et al.
Publicado: (2018)